Paul Floreancig earned his BS degree from Indiana University in 1986 and completed his MS at Yale University in 1989 while working for Fred Ziegler. He moved to Eli Lilly to work as a medicinal chemist for two years and worked on the design and synthesis of leukotriene B4 antagonists. In 1991 he moved to Stanford where he completed his PhD with Paul Wender and was a member of the team that synthesized Taxol. In 1997 he moved to Caltech as an NIH postdoctoral fellow in Peter Dervan’s group, where he worked on the design, synthesis, and analysis of sequence-selective ligands for DNA. He joined the Department of Chemistry at the University of Pittsburgh in 1999 as an assistant professor, then was promoted to associate professor in 2005 and professor in 2010. His research interests are reaction development, natural product and analog synthesis, mechanism elucidation, and drug delivery. He has taught courses in introductory organic synthesis (large lecture and honors), organic synthesis, mechanistic organic chemistry, spectroscopy, and photochemistry and electron transfer. Outside of work he enjoys family time, cycling, reading, music, and travel.
 
For a profile that appeared in Angewandte Chemie, International Edition, see:
https://onlinelibrary.wiley.com/doi/10.1002/anie.201103836
​